Literature DB >> 7541981

The relation between depth of trophoblastic invasion and beta-HCG levels in tubal pregnancies.

M Klein1, A Graf, H Kiss, K Czerwenka, A Beck, C Egarter, P Husslein.   

Abstract

beta-HCG (human chorionic gonadotropin) values of over 2500 I.U./l are associated with higher failure rates for therapy with prostaglandin F2 alpha in tubal pregnancies. The purpose of our study was to ascertain if the 2500 I.U./l limit correlates with histopathology. We therefore compared the pre-operative beta-HCG-values and intraluminal and extraluminal trophoblast growth in tubal pregnancy. Purely intraluminal trophoblast was significantly more frequent in patients of group I (beta-HCG < 2500 I.U./l), while group II patients (beta-HCG > 2500 I.U./l) almost exclusively had extraluminal growth (P = 0.0045). Since the efficacy of prostaglandin F2 alpha therapy depends on intact tubal musculature the correlation of the beta-HCG threshold level with histopathologic findings may explain the high failure rate in patients with beta-HCG values above 2500 I.U./l.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541981     DOI: 10.1007/bf00634713

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

1.  [Treatment concepts in tubal pregnancy].

Authors:  P Husslein; C Egarter; R Fitz; H Kiss; J Spona
Journal:  Wien Klin Wochenschr       Date:  1990-08-03       Impact factor: 1.704

2.  Local application of hyperosmolar glucose solution in tubal pregnancy.

Authors:  P Lang; P A Weiss; H O Mayer
Journal:  Lancet       Date:  1989-10-14       Impact factor: 79.321

3.  Serum beta-human chorionic gonadotropin levels relate poorly with the size of a tubal pregnancy.

Authors:  P S Cartwright; R A Moore; A H Dao; S W Wong; J R Anderson
Journal:  Fertil Steril       Date:  1987-10       Impact factor: 7.329

4.  Anatomy and pathology of tubal pregnancy.

Authors:  C J Pauerstein; H B Croxatto; C A Eddy; I Ramzy; M D Walters
Journal:  Obstet Gynecol       Date:  1986-03       Impact factor: 7.661

5.  Treatment of tubal pregnancy by prostaglandins.

Authors:  C Egarter; P Husslein
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

6.  Management of tubal pregnancy with methotrexate.

Authors:  H Zakut; O Sadan; A Katz; D Dreval; D Bernstein
Journal:  Br J Obstet Gynaecol       Date:  1989-06

7.  [Treatment of tubal pregnancy with prostaglandins: a multicenter study].

Authors:  C Egarter; R Fitz; J Spona; W Grünberger; P Wagenbichler; R Haidbauer; K Baumgarten; A Beck; S Leodolter; H Kiss
Journal:  Geburtshilfe Frauenheilkd       Date:  1989-09       Impact factor: 2.915

8.  Local prostaglandin F2 alpha injection for termination of ectopic pregnancy.

Authors:  B Lindblom; M Hahlin; B Källfelt; L Hamberger
Journal:  Lancet       Date:  1987-04-04       Impact factor: 79.321

  8 in total
  2 in total

1.  Human chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase and AKT signaling.

Authors:  Johanna Prast; Leila Saleh; Heinrich Husslein; Stefan Sonderegger; Hanns Helmer; Martin Knöfler
Journal:  Endocrinology       Date:  2007-12-06       Impact factor: 4.736

Review 2.  Human trophoblast function during the implantation process.

Authors:  Elsebeth Staun-Ram; Eliezer Shalev
Journal:  Reprod Biol Endocrinol       Date:  2005-10-20       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.